Stockreport

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today provided a preliminary update on f [Read more]